Literature DB >> 11978637

Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter.

Nobuhiro Ban1, Yuichiro Yamada, Yoshimichi Someya, Kazumasa Miyawaki, Yu Ihara, Masaya Hosokawa, Shinya Toyokuni, Kinsuke Tsuda, Yutaka Seino.   

Abstract

Mutations in the hepatocyte nuclear factor (HNF)-1alpha gene have been linked to subtype 3 of maturity-onset diabetes of the young (MODY), a disease characterized by a primary defect in insulin secretion. Here we show that the human GLUT2 gene is closely regulated by HNF-1alpha via sequences downstream of the transcriptional start site by interaction with transcriptional co-activator p300. The promoter region of the human GLUT2 gene was subcloned into luciferase expression plasmids that were transfected together with HNF-1alpha expression plasmid into a pancreatic beta-cell line, HIT-T15, to evaluate transcriptional activities. HNF-1alpha enhanced human GLUT2 promoter activity sixfold. Site-direct mutagenesis and footprint analyses showed that the HNF-1alpha binding site (+200 to +218) is critical in human GLUT2 gene expression. Furthermore, mammalian two-hybrid and immunoprecipitation studies revealed the transactivation domain of HNF-1alpha (amino acids 391-540) to interact with both the NH(2)-terminal region (amino acids 180-662) and the COOH-terminal region (amino acids 1,818-2,079) of p300. These findings demonstrated that HNF-1alpha binds to the 5'-untranslated region of GLUT2 and that p300 acts as a transcriptional co-activator for HNF-1alpha. In addition, these results provided new insight into the regulatory function of HNF-1alpha by suggesting a molecular basis for human GLUT2 gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978637     DOI: 10.2337/diabetes.51.5.1409

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

1.  Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.

Authors:  Diana E Stanescu; Nkecha Hughes; Bernard Kaplan; Charles A Stanley; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2012-07-16       Impact factor: 5.958

Review 2.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

3.  Functional analyses of the mutation nt-128 T→G in the hepatocyte nuclear factor-1α promoter region in Chinese diabetes pedigrees.

Authors:  Q Fang; S Chen; Y Wang; S Jiang; R Zhang; C Hu; C Wang; F Liu; K Xiang; W Jia
Journal:  Diabet Med       Date:  2012-11       Impact factor: 4.359

4.  Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3.

Authors:  K-A Kim; K Kang; Y-I Chi; I Chang; M-K Lee; K-W Kim; S E Shoelson; M-S Lee
Journal:  Diabetologia       Date:  2003-04-24       Impact factor: 10.122

5.  Hepatocyte nuclear factor 4alpha enhances the hepatocyte nuclear factor 1alpha-mediated activation of transcription.

Authors:  J Eeckhoute; P Formstecher; B Laine
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

6.  Functional differences between aggregated and dispersed insulin-producing cells.

Authors:  A Chowdhury; O Dyachok; A Tengholm; S Sandler; P Bergsten
Journal:  Diabetologia       Date:  2013-04-19       Impact factor: 10.122

7.  MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells.

Authors:  Martin E Fernandez-Zapico; Jennifer C van Velkinburgh; Ruth Gutiérrez-Aguilar; Bernadette Neve; Philippe Froguel; Raul Urrutia; Roland Stein
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

8.  The nucleosome binding protein HMGN3 modulates the transcription profile of pancreatic beta cells and affects insulin secretion.

Authors:  Tetsuya Ueda; Takashi Furusawa; Toshihiro Kurahashi; Lino Tessarollo; Michael Bustin
Journal:  Mol Cell Biol       Date:  2009-08-03       Impact factor: 4.272

9.  Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.

Authors:  Fabián Arenas; Isabel Hervias; Miriam Uriz; Ruth Joplin; Jesús Prieto; Juan F Medina
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 10.  Epigenetics: a molecular link between environmental factors and type 2 diabetes.

Authors:  Charlotte Ling; Leif Groop
Journal:  Diabetes       Date:  2009-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.